APA (7th ed.) Citation

Ongphichetmetha, T., Jitprapaikulsan, J., Siritho, S., Rattanathamsakul, N., Detweeratham, T., & Prayoonwiwat, N. (2024, February). Efficacy and safety of rituximab in multiple sclerosis and neuromyelitis optica spectrum disorder. Scientific Reports.

Chicago Style (17th ed.) Citation

Ongphichetmetha, Tatchaporn, Jiraporn Jitprapaikulsan, Sasitorn Siritho, Natthapon Rattanathamsakul, Thammachet Detweeratham, and Naraporn Prayoonwiwat. "Efficacy and Safety of Rituximab in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder." Scientific Reports Feb. 2024.

MLA (9th ed.) Citation

Ongphichetmetha, Tatchaporn, et al. "Efficacy and Safety of Rituximab in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder." Scientific Reports, Feb. 2024.